OptymEdge
OptymEdge provides AI-powered platforms and visual function certification services for ophthalmology clinical trials, serving pharma sponsors, CROs, and 2,500+ clinical trial sites globally through its Acuvera Suite.
- Company typePrivate
- Founded2004
- HeadquartersRockville, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What OptymEdge does
OptymEdge is a privately held US company that provides AI-enabled technology platforms and specialized certification services for ophthalmology clinical trials. The company targets three primary buyer segments: pharmaceutical and biotech sponsors, contract research organizations (CROs), and the clinical trial sites that execute ophthalmic studies, with a claimed global footprint covering 2,500+ clinical sites. Headquartered in Rockville, Maryland, and organized as OptymEdge, LLC, the company asserts 30+ years of ophthalmic domain expertise and operates with 51–100 employees. Footer links to The Emmes Group's privacy notice and terms of use suggest a possible affiliation with Emmes, though no formal parent-subsidiary relationship is stated.
The company's core offering is the Acuvera Suite, an integrated platform built around three modules: Acuvera Capture (digital visual function data capture with automated BCVA calculations, guided visit workflows, and CFR Part 11 compliance), Acuvera Imaging (central imaging reading services with AI-assisted quality control across CFP, FA, FAF, OCT, OCT-A, and microperimetry modalities), and Acuvera Certify (assessment-based examiner and site certification that powers the Certified Site Network). Embedded AI capabilities include computer vision for image QC grading, anomaly detection for formatting, labeling, and PHI exposure, and process automation for BCVA calculations and RBQM-style insights. The platform is GCP, HIPAA, GDPR, and CFR Part 11 compliant, and is positioned as a paper-eliminating, audit-ready system for multi-center global trials.
OptymEdge runs a hybrid revenue model combining subscription-style platform access (Acuvera Suite) with project-based professional services (visual function certification, tailored training, and central imaging reading). Pricing is not publicly disclosed and is negotiated via an RFP process under multi-year enterprise contracts. The go-to-market motion is consultative enterprise sales with dedicated project managers and clinical leads per study, supplemented by strategic channel partnerships—most recently a collaboration announced with Streetlab in April 2026 to extend Virtual Reality–based functional vision assessments into regulated trials.
OptymEdge firmographics
Firmographics- Name
- OptymEdge
- Legal name
- OptymEdge, LLC
- Website
- https://optymedge.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- OptymEdge provides AI-powered platforms and visual function certification services for ophthalmology clinical trials, serving pharma sponsors, CROs, and 2,500+ clinical trial sites globally through its Acuvera Suite.
- Ownership category
- akta.pro rank
OptymEdge industry classification
Industry- Product category
- Clinical Trial Technology
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industries
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
Keywords
Where OptymEdge is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Markets served
OptymEdge business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Visual Function Certification Services: Assessment-based certification for sites and examiners including BCVA, ETDRS refraction, contrast sensitivity testing, and other visual function endpoints. Covers initial validation, ongoing management, and annual recertification.
- Acuvera Digital Solutions Platform: AI-powered technology platform including Capture (data capture), Imaging (central reading), and Certify (certification management) sold as integrated suite to clinical trial sponsors and CROs.
- Tailored Training Services: Customized services including In-house Team Training, Equipment & Examination Room Inspection, Protocol Consultation, Investigator Meeting Training, and SIV training.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Project-based pricing via RFP |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
OptymEdge product offering
Product offeringCore offering
OptymEdge develops and sells the AI-powered Acuvera Suite, an integrated platform for ophthalmology clinical trials that combines visual function data capture (Capture), central imaging reading with AI-assisted QC (Imaging), and site/examiner certification management (Certify). The company also delivers professional certification and training services for visual function endpoints such as BCVA, ETDRS refraction, and contrast sensitivity, and maintains a Certified Site Network of 2,500+ clinical centers globally.
Product overview
OptymEdge offers the Acuvera Suite, an integrated platform architecture comprising three core modules: Acuvera Capture (visual function data capture with automated BCVA calculations), Acuvera Imaging (regulatory-ready central imaging with AI-assisted QC), and Acuvera Certify (assessment-based certification with Certified Site Network). Supporting services include comprehensive visual function testing certification (ETDRS refraction, VA, contrast sensitivity, etc.) and a database of 2,500+ clinical sites. The platform is AI-powered with RBQM insights and integrates with EDC systems for seamless data transfer.
Differentiator
Problem solved
Functional benefit
Products and services
- Acuvera Suite AI-powered integrated suite of technology solutions purpose-built for ophthalmology clinical trials. Unifies visual function data capture (Capture), central imaging reading services (Imaging), and examiner/site certification (Certify) with RBQM insights and endpoint-specific intelligence for clinical trial sponsors and CROs.
- Acuvera Capture Visual function data capture platform designed by ophthalmic experts that eliminates paper, reduces errors, and streamlines data flow with built-in logic and automated BCVA calculations. CFR Part 11-aligned and audit-ready, with seamless EDC integration for sponsors and trial sites.
- Acuvera Imaging Regulatory-ready central imaging services delivering standardized, unbiased grading and advanced AI-assisted QC for ophthalmology clinical trials. Supports all phases from early-phase to global multi-center trials across CFP, FA, FAF, OCT, OCT-A, and Microperimetry modalities.
- Acuvera Certify Assessment-based, centrally tracked certification platform for sites and examiners with cross-study tracking and annual recertification. Powers a data-driven Certified Site Network enabling faster site activation and standardized examiner oversight.
- Visual Function Testing Certification Comprehensive certification services for visual function assessments including Standard and Electronic ETDRS Refraction, ETDRS Visual Acuity, Pelli Robson Contrast Sensitivity, Mars Contrast Sensitivity, BRVT, NEI VFQ-25, Tonometry, Color Vision Testing, Reading Speed Testing, and Low Luminance Testing.
- BCVA Certification Services Training and certification services for Best Corrected Visual Acuity (BCVA) assessment using ETDRS protocols, including examiner certification, equipment inspection, and examination room certification for ophthalmic trial sites.
- Clinical Site Database Database of 2,500+ clinical centers worldwide (academic institutions and private practice settings) with maintained certification status, enabling rapid assessment of site readiness for patient screening and enrollment in ophthalmology trials.
- Tailored Training Services Customized services including In-house Team Training, Equipment and Examination Room Inspection, Protocol Consultation, Investigator Meeting Training, and SIV training to support ophthalmology trial execution.
Quantifiable outcome
- Faster first-patient-in through pre-certification matching and streamlined onboarding
- +3 more outcomes
Companies that use OptymEdge
Customer profileSegments3 records
Ideal customer profiles3 records
OptymEdge technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
OptymEdge partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- StreetlabcoreStrategic collaboration to expand the use of Virtual Reality for real-life functional vision assessments in regulated clinical trials. The partnership combines OptymEdge's expertise in standardized visual function endpoints—including BCVA assessment, examiner training, and certification—with Streetlab's pioneering work in real-life functional vision and mobility testing. The organizations aim to create scalable pathways for integrating functional vision endpoints into global clinical studies, enabling sponsors and CROs to incorporate patient-relevant measures alongside traditional endpoints.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
OptymEdge competitors and assessment
Company assessmentBroad incumbents
- ICON plc: ICON is a large global CRO offering comprehensive clinical development and laboratory services, including an ophthalmology franchise and central imaging capabilities. It competes with OptymEdge on multi-center ophthalmology trials where scale and geographic reach matter.
- IQVIA: IQVIA is one of the world's largest CROs with a global ophthalmology practice and end-to-end clinical trial services. As a broad incumbent, it competes for large ophthalmology engagements where sponsors prefer to consolidate vendors with a single primary CRO partner.
- Parexel: Parexel is a global CRO with established ophthalmology expertise and end-to-end Phase I–IV services. It is a broad incumbent that often competes with OptymEdge for ophthalmology trial work, particularly through its Functional Service Provider (FSP) partnerships with sponsors.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-tier CRO with deep ophthalmology expertise and central imaging services. It is a comparable broad incumbent in the ophthalmology trial services space, particularly for CNS and ophthalmology adjacencies.
- Medpace: Medpace is a mid-to-large CRO with strong therapeutic area specialization and an ophthalmology practice. Its full-service model and embedded medical monitors compete with OptymEdge for sponsor ophthalmology engagements, particularly in mid-sized biotech trials.
Others
- Veeva Systems: Veeva provides cloud-based clinical trial platforms (Veeva Vault CTMS, eTMF, CDB) used by many of the same sponsors and CROs OptymEdge serves. It is an adjacent technology provider rather than a direct competitor, but increasingly offers EDC and clinical data capabilities that overlap with parts of the Acuvera Suite.
- Medidata (Dassault Systèmes): Medidata provides the Rave EDC and clinical trial analytics platform widely used by sponsors and CROs, including those running ophthalmology trials. It is an enabling technology provider whose platform integrations shape how OptymEdge's Capture module connects into sponsor data workflows.
Emerging players
- Clario: Clario provides clinical trial technology and central imaging services including ophthalmology imaging endpoints. It is an emerging direct competitor in AI-enabled central imaging and endpoint data capture, overlapping with OptymEdge's Acuvera Imaging module.
Direct peers
- Ora: Ora is a leading ophthalmic-focused clinical research organization offering preclinical and clinical development services for ophthalmology products. It directly competes with OptymEdge in serving ophthalmology trial sponsors and CROs with full-service trial support.
- Lexitas Pharma Services: Lexitas is a specialty CRO providing ophthalmology-focused clinical trial services including imaging, biostatistics, and medical writing. It is closely comparable to OptymEdge's combination of central imaging reading, data capture, and certification support for ophthalmic trials.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
OptymEdge social profiles
Digital presenceOptymEdge compliance and trust
Trust signalCompliance4 records
OptymEdge financial estimates
Financial estimateRevenue estimate
Valuation estimate
OptymEdge leadership team
Management profileNumber of profiles
Profiles6 records
OptymEdge funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OptymEdge M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OptymEdge
What does OptymEdge do?
OptymEdge develops and sells the AI-powered Acuvera Suite, an integrated platform for ophthalmology clinical trials that combines visual function data capture (Capture), central imaging reading with AI-assisted QC (Imaging), and site/examiner certification management (Certify). The company also delivers professional certification and training services for visual function endpoints such as BCVA, ETDRS refraction, and contrast sensitivity, and maintains a Certified Site Network of 2,500+ clinical centers globally.
Is OptymEdge a public or private company?
OptymEdge is a private company. It is classified as corporate owned and is currently operating.
When was OptymEdge founded?
OptymEdge was founded in 2004. It employs 51 to 100 people.
Where is OptymEdge based?
OptymEdge is headquartered in Rockville, United States, in the North America region.
How does OptymEdge make money?
Three revenue lines are on record. Visual Function Certification Services are the primary driver. The others are acuvera Digital Solutions Platform and tailored Training Services.
Who are OptymEdge's main competitors?
Broad incumbents on record are ICON plc, IQVIA, Parexel, Worldwide Clinical Trials and Medpace. Others are Veeva Systems and Medidata (Dassault Systèmes). Clario is listed as an emerging player. Direct peers are Ora and Lexitas Pharma Services.
Does OptymEdge have an API?
No public API is recorded for OptymEdge.
What industry is OptymEdge in?
OptymEdge's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity). Its NAICS code is 5417 and its SIC code is 3841.